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Abstract: Cutaneous lupus erythematosus (CLE) in humans encompasses multiple subtypes that
exhibit a wide array of skin lesions and, in some cases, are associated with the development
of systemic lupus erythematosus (SLE). We investigated dogs with exfoliative cutaneous lupus
erythematosus (ECLE), a dog-specific form of chronic CLE that is inherited as a monogenic autosomal
recessive trait. A genome-wide association study (GWAS) with 14 cases and 29 controls confirmed
a previously published result that the causative variant maps to chromosome 18. Autozygosity
mapping refined the ECLE locus to a 493 kb critical interval. Filtering of whole genome sequence data
from two cases against 654 controls revealed a single private protein-changing variant in this critical
interval, UNC93B1:c.1438C>A or p.Pro480Thr. The homozygous mutant genotype was exclusively
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observed in 23 ECLE affected German Shorthaired Pointers and an ECLE affected Vizsla, but absent
from 845 controls. UNC93B1 is a transmembrane protein located in the endoplasmic reticulum
and endolysosomes, which is required for correct trafficking of several Toll-like receptors (TLRs).
The p.Pro480Thr variant is predicted to affect the C-terminal tail of the UNC93B1 that has recently
been shown to restrict TLR7 mediated autoimmunity via an interaction with syndecan binding protein
(SDCBP). The functional knowledge on UNC93B1 strongly suggests that p.Pro480Thr is causing
ECLE in dogs. These dogs therefore represent an interesting spontaneous model for human lupus
erythematosus. Our results warrant further investigations of whether genetic variants affecting the
C-terminus of UNC93B1 might be involved in specific subsets of CLE or SLE cases in humans and
other species.
Keywords: Canis familiaris; dermatology; immunology; animal model; skin; TLR7; toll-like receptor;
syndecan binding protein; syntenin-1; systemic lupus erythematosus; SLE; CLE
1. Introduction
In humans, cutaneous lupus erythematosus (CLE) represents a group of lupus erythematosus
(LE)-associated autoimmune skin diseases exhibiting a cell-rich interface dermatitis leading to erosions
and ulcerations with subsequent scarring, disfiguration and decreased quality of life [1–4]. CLE can
affect only the skin or be present as part of a diverse range of potentially life-threatening and debilitating
symptoms in patients with systemic lupus erythematosus (SLE) [1–4].
The incidence of CLE has been reported at ~4 cases per 100,000 persons per year [5–8]; 10% to 30%
of human patients with CLE exhibit a transition from cutaneous into SLE forms, suggesting shared
pathways and genetic background relevant to both cutaneous and systemic manifestations [5,6,9].
It has been proposed that some CLE forms, similarly to SLE, have an underlying genetic
predisposition that combines with environmental factors to elicit an abnormal immune response with
a continuous activation of the innate immune system. Several genetic associations have been identified
in human CLE, with the majority of them involving type I interferon pathways, cell death and clearance
of cell debris, antigen presentation and immune cell regulation [10,11]. To date, a single monogenic
form of CLE caused by heterozygous variants in the TREX1 gene encoding the three prime repair
exonuclease has been identified in human patients with familial chilblain lupus erythematosus [12].
The pathogenic TREX1 variants lead to chronic hyperactivation of the type I interferon system via
cytosolic DNA recognition pathways [11,13]. A rare monogenic form of SLE in humans is caused
by variants in the DNASE1 gene encoding deoxyribonuclease 1 [14]. Mice deficient for Dnase I also
develop an SLE-like autoimmune disease [15].
Dogs may also suffer from various forms of CLE, some of which resemble or are identical to their
human homologs [4]. The so-called exfoliative cutaneous lupus erythematosus (ECLE) is a dog-specific
variant of chronic CLE that has a very strong hereditary component and appears to be inherited as a
monogenic autosomal trait [16–18]. Despite its current designation, signs of ECLE are not restricted
to the skin. In most patients, ECLE starts with characteristic skin lesions in juvenile or young adult
dogs (Figure 1). In later stages, ECLE often additionally affects the joints with severe pain, but a
progression to classic antinuclear antibody-positive SLE is usually not seen [4,16–18]. The treatment of
ECLE-affected dogs with immunomodulatory drugs often is insufficient to achieve long-lasting control
of the disease, leading to a guarded prognosis [18,19]. Dogs affected with ECLE often are euthanized
due to the severity of their disease. ECLE has been observed in several closely related hunting dog
breeds, German Shorthaired Pointers, Braques du Bourbonnais, and Vizslas.
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Figure 1. Exfoliative Cutaneous Lupus Erythematosus (ECLE) phenotype. (A) Scarring alopecia, 
generalized hair loss and adherent crusts on the face of a 2-year-old male dog. (B) Erythematous 
lesions on the back of a 1.5-year old male dog. (C) Close up of patchy lesions on the abdomen. (D) 
Haired skin from an ECLE affected dog with typical histological changes that include a cell-rich 
interface inflammation with frequent basal keratinocyte apoptosis (arrows). Hematoxylin and eosin 
stain. 
A previously reported genome-wide association study (GWAS) mapped the causative genetic 
defect for ECLE to chromosome 18, but the causative variant has not yet been identified [20]. The 
best-associated marker was located at position 53,913,829 (CanFam 2) [20], which corresponds to 
50,888,317 in the current CanFam 3.1 assembly. 
In the present study, we performed a new GWAS followed by a whole genome sequencing 
approach with the goal to identify the causative genetic variant for ECLE in dogs. 
2. Materials and Methods  
2.1. Ethics Statement 
All the dogs in this study were privately owned and samples were collected with the consent of 
their owners. The collection of blood samples was approved by the “Cantonal Committee for Animal 
Experiments” (Canton of Bern; permit 75/16). 
2.2. Animal Selection 
This study included 877 dogs. They consisted of 552 German Shorthaired Pointers (26 ECLE 
cases/526 controls), 52 unaffected German Longhaired Pointers, 210 unaffected German Wirehaired 
Pointers, 7 unaffected Braques du Bourbonnais, and 56 Vizslas (1 ECLE case/55 controls). The 27 
ECLE cases were diagnosed by licensed veterinarians. The 850 dogs classified as unaffected 
represented population controls without reports of severe immunological or skin-related health 
issues. Peripheral blood samples were collected in EDTA vacutainers and stored at −20°C. Additional 
details on samples are given in Table S1. 
2.3. DNA Extraction and SNV Genotyping 
Genomic DNA was either available from a previous study [20], isolated from EDTA blood with 
the Maxwell RSC Whole Blood Kit using a Maxwell RSC instrument (Promega, Dübendorf, 
Switzerland), or from formalin-fixed paraffin-embedded (FFPE) tissue samples using the Maxwell 
RSC DNA FFPE kit according to the manufacturer’s instructions. DNA from 14 ECLE cases and 29 
controls was genotyped on illumina_HD canine BeadChips containing 220,853 markers (Neogen, 
Lincoln, NE, USA). The raw SNV genotypes are available in File S1. We did not have complete 
pedigree information on all 43 dogs that were genotyped on the SNV arrays. Some of the dogs were 
closely related, including, for example, 5 cases that were full siblings. Table S2 lists the pairwise IBD 
between all dogs and gives an objective measure of the relatedness between the genotyped dogs. A 
multiple dimension scaling (MDS) plot is shown in Figure S1. 
The previously published GWAS [20] had been done with Affymetrix v2 127 k SNV genotyping 
arrays. A total of 6 cases and 2 controls were shared between the two analyses. The other 35 samples 
herein were from dogs different from those of the previous study. 
Figure 1. Exfoliative Cutaneous Lupus Erythe atosus (E LE) phenotype. (A) Scarring alopecia,
generalized hair loss and adherent crusts on the face of a 2-year-old male dog. (B) Erythematous lesions
on the back of a 1.5-year old male dog. (C) Close up of patchy lesions on the abdomen. (D) Haired
skin from an ECLE affected dog with typical histological changes that include a cell-rich interface
inflammation with frequent basal keratinocyte apoptosis (arrows). Hematoxylin and eosin stain.
A previously reported genome-wide association study (GWAS) mapped the causative genetic
defect for ECLE to chromosome 18, but the causative variant has not yet been identified [20].
The best-associated marker was located at position 53,913,829 (CanFam 2) [20], which corresponds to
50,888,317 in the current CanFam 3.1 assembly.
In the present study, we performed a new GWAS followed by a whole genome sequencing
approach with the goal to identify the causative genetic variant for ECLE in dogs.
2. Materials and Methods
2.1. Ethics Statement
All the dogs in this study were privately owned and samples were collected with the consent of
their owners. The collection of blood samples was approved by the “Cantonal Committee for Animal
Experiments” (Canton of Bern; permit 75/16).
2.2. Animal Selection
This study included 877 dogs. They consisted of 552 German Shorthaired Pointers (26 ECLE
cases/526 controls), 52 unaffected German Longhaired Pointers, 210 unaffected German Wirehaired
Pointers, 7 unaffected Braques du Bourbonnais, and 56 Vizslas (1 ECLE case/55 controls). The 27 ECLE
cases were diagnosed by licensed veterinarians. The 850 dogs classified as unaffected represented
population controls without reports of severe immunological or skin-related health issues. Peripheral
blood samples were collected in EDTA vacutainers and stored at −20◦C. Additional details on samples
are given in Table S1.
2.3. DNA Extraction and SNV Genotyping
Genomic DNA was either available from a previous study [20], isolated from EDTA blood with the
Maxwell RSC Whole Blood Kit using a Maxwell RSC instrument (Promega, Dübendorf, Switzerland),
or from formalin-fixed paraffin-embedded (FFPE) tissue samples using the Maxwell RSC DNA FFPE kit
according to the manufacturer’s instructions. DNA from 14 ECLE cases and 29 controls was genotyped
on illumina_HD canine BeadChips containing 220,853 markers (Neogen, Lincoln, NE, USA). The raw
SNV genotypes are available in File S1. We did not have complete pedigree information on all 43 dogs
that were genotyped on the SNV arrays. Some of the dogs were closely related, including, for example,
5 cases that were full siblings. Table S2 lists the p ir is IBD between all dogs and gives an objective
measur of the relate ness between the genotyp d dogs. A multiple dim nsion scaling (MDS) plot is
shown in Figure S1.
The previously published AS [20] ith Affymetrix v2 127 k SNV genotyping
arrays. A total of 6 cases and 2 co tr l t e the two analyses. The other 35 samples
her in wer from dogs different from those of the r i t .
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For some dogs from the previous study [20] only very little DNA was left. The remaining DNA of 8
German Shorthaired Pointers was used up for SNV genotyping on the illumina_HD canine BeadChips.
In these dogs, no specific targeted genotyping could be performed (see Section 2.8 below).
2.4. GWAS and Autozygosity Mapping
We used PLINK v.1.9 for basic file manipulation of the SNV genotypes [21]. We removed markers
and individuals with less than 90% call rates. We further removed markers with minor allele frequency
of less than 10% and markers deviating from the Hardy–Weinberg equilibrium in controls with a
p-value of less than 10−5. An allelic GWAS was then performed with the GEMMA 0.98 software using
a linear mixed model including an estimated kinship matrix as covariable to correct for the genomic
inflation [22]. Manhattan and QQ plots of the corrected p-values were generated in R [23].
For autozygosity mapping, the genotype data of 14 ECLE cases were used. A tped-file containing
the markers on chromosome 18 was visually inspected in an Excel spreadsheet to find a homozygous
shared haplotype in the cases (Table S3).
2.5. Whole Genome Sequencing of Two Affected German Shorthaired Pointers
Illumina TruSeq PCR-free DNA libraries with ~450 bp insert size of two affected German
Shorthaired Pointers without known relationships were prepared. We collected 277 and 160 million
2 × 150 bp paired-end reads on a NovaSeq 6000 instrument corresponding to 29.3× and 17.9× coverage,
respectively. Mapping and alignment were performed as described previously [24]. The sequence
data were deposited under study accession PRJEB16012 and sample accessions SAMEA5657398 and
SAMEA6249504 at the European Nucleotide Archive.
2.6. Variant Calling
Variant calling was performed using GATK HaplotypeCaller [25] in gVCF mode as described [24].
To predict the functional effects of the called variants, SnpEff [26] software together with NCBI
annotation release 105 for the CanFam 3.1 genome reference assembly was used. For variant filtering
we used 654 control genomes, which were either publicly available [27,28] or produced during other
projects of our group [24] (Table S4).
2.7. Gene Analysis
We used the CanFam 3.1 dog reference genome assembly and NCBI annotation release 105.
Numbering within the canine UNC93B1 gene corresponds to the NCBI RefSeq accession numbers
XM_540813.6 (mRNA) and XP_540813.3 (protein).
2.8. Sanger Sequencing
The UNC93B1:c.1438C>A variant was genotyped by direct Sanger sequencing of PCR amplicons.
On high-quality genomic DNA samples, a 399 bp PCR product was amplified from genomic DNA
using AmpliTaqGold360Mastermix (Thermo Fisher Scientific, Waltham, MA, USA) together with
primers 5‘-ATC CGT GTC TGT GCC CTC A-3‘ (Primer F) and 5’-CGA CCT GAG ACG CGG TAA
A-3’ (Primer R). For FFPE-derived DNA samples, a smaller amplicon of 124 bp was amplified with
the primers 5’-CCT CGT ACC TGT GGA TGG AG-3’ (Primer F2) and 5’-CTC TCG TCG GAG TTG
TCC TC-3’ (Primer R2). After treatment with exonuclease I and alkaline phosphatase, amplicons were
sequenced on an ABI 3730 DNA Analyzer (Thermo Fisher Scientific). Sanger sequences were analyzed
using the Sequencher 5.1 software (GeneCodes, Ann Arbor, MI, USA).
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3. Results
3.1. Mapping of the ECLE Locus
We performed a GWAS with genotypes from 43 German Shorthaired Pointers. After quality
control, the pruned dataset consisted of 14 ECLE cases, 29 controls and 116,891 markers. We obtained a
single association signal with 35 markers exceeding a suggestive significance threshold of p = 5 × 10−5
after adjustment for genomic inflation. All associated markers were located on chromosome 18 within
an interval spanning from 49.0 Mb–53.9 Mb. The top-associated marker at Chr18:49,835,345 had a
p-value of 1.5 × 10−6 (Figure 2).
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Shared homozygous variants in whole genome 1,420,602 
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Shared homozygous variants in 493 kb critical interval 851 
Private variants (absent from 654 control genomes) in critical interval 2 
Protein changing private variants in critical interval 1 
One of the two private variants in the critical interval, Chr18:49,733,311C>T, was located in an 
intron of the CHKA gene and thus not investigated further. The other variant, Chr18:49,834,825C>A 
was a missense variant in the last exon of the UNC93B1 gene. The formal designation of this variant 
is XM_540813.6:c.1438C>A or XP_540813.3:p.(Pro480Thr). It is predicted to change a highly conserved 
amino acid in the C-terminal tail of the UNC93B1 protein. We confirmed the variant by Sanger 
sequencing (Figure 3). 
Figure 2. Map ing of the E l e- ide a sociation. (A) Manh ttan plot illus rating a
single signal on chrom some 18. The dashed red lin indicates the thres old for suggestive si nificance
at p = 5 × 10−5 according to [29]. The best associated marker id not reach the stringent Bo ferroni
significance threshold (pBonf. = 4.3 × 10−7) due to several close relationships and extreme genomic
inflation in the dataset. The genomic inflation factor was 1.90 before and 0.99 after the correction.
(B) The quantile–quantile (QQ) plot shows the observed versus expected –log(p) values. The straight
red line in the QQ plot indicates the distribution of p-values under the null hypothesis. The deviation
of p-values at the right side indicates that these markers are stronger associated with the trait than
would be expected by chance. This supports the biological significance of the association.
To narrow down the identified region, we visually inspected the genotypes of the cases and
perform d an autozygosity mapping. We searched for homozygous regi ns with allele sharing and
found one region of ~493 kb which was shared betw en all 14 cas s. The critical interv l for the
causative ECLE variant corresponded to the interval between the first flanking het ozygous markers
on either si e o the homozygous segment or Chr18:49,545,431-50,038,225 (CanFam 3.1 assembly).
3.2. Identification of a Candidate Causative Variant
We sequenced the genome of two affected dogs at 29.3 × and 17.9 × coverage and called SNVs
and small indel variants with respect to the reference genome. We then compared these variants
to whole genome sequence data of 8 wolves and 646 control dogs from genetically diverse breeds.
This analysis identified two private homozygous variants in the critical interval in the affected dogs
(Table 1). A visual inspection of the short read alignments ruled out any additional structural variants
affecting protein-coding sequences in the critical interval in the two sequenced cases.
Table 1. Variants detected by whole genome re-sequencing of two ECLE-affected dogs.
Filtering Step Vari nts
Shared homozygous variants in whole genome 1,420,602
Private homozygous variants (absent from 654 control genomes) in whole genome 25
Shared homozygous variants in 493 kb critical interval 851
Private variants (absent from 654 control genomes) in critical interval 2
Protein changing private variants in critical interval 1
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One of the two private variants in the critical interval, Chr18:49,733,311C>T, was located in an
intron of the CHKA gene and thus not investigated further. The other variant, Chr18:49,834,825C>A
was a missense variant in the last exon of the UNC93B1 gene. The formal designation of this variant is
XM_540813.6:c.1438C>A or XP_540813.3:p.(Pro480Thr). It is predicted to change a highly conserved
amino acid in the C-terminal tail of the UNC93B1 protein. We confirmed the variant by Sanger
sequencing (Figure 3).Genes 2020, 10, x FOR PEER REVIEW 6 of 10 
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Figure 3. Details of the 93 1 isse se ariant. (A) Representative Sanger electropherograms
from dogs with the three different genotypes at c.1438C>A are shown. The amino acid translation
is indicated. (B) Evolutionary conservation of the SDCBP binding domain [30]. The proline at
position 480 of the canine UNC93B1 protein is strictly conserved across all vertebrates. The sequences
were derived from the following database accessions: dog XP_540813.3, human NP_112192.2, cow
XP_540813.3, horse XP_023510352.1, mouse NP_062322.2, rat NP_001101983.1, chicken XP_004941322.1,
frog NP_001093723.1, zebrafish XP_0026660582.1. (C) Scanning-alanine mutagenesis in mouse
macrophages identified four mutants that disrupt SDCBP binding and lead to upregulated TLR7
signaling [30]. The altered residues in these mutants are underlined.
3.3. Genotype Phenotype Association of the UNC93B1:p.Pro480Thr Variant
We genotyped 544 German Shorthaired Pointers for the p.Pro480Thr variant and found a near
perfect association of the genotypes at this variant with ECLE (pFisher = 1.2 × 10−39). None of the
520 genotyped controls were homozygous for the mutant A/A genotype. However, one of the
24 genotyped cases was not homozygous A/A. We speculate that this single discordant dog is likely due
to a phenotyping error as it had an atypically late age of onset and was not clinically confirmed as having
ECLE by a board certified veterinary dermatologist (Table S1). The analysis of additional animals from
related hunting dog breeds revealed the presence of the mutant allele in German Longhaired Pointers
and Vizslas. A single ECLE-affected Vizsla also had the homozygous mutant A/A genotype (Table 2).
Table 2. Association of the genotypes at UNC93B1:c.1438C>A with ECLE.
ECLE Phenotype Breed C/C C/A A/A
Affected German Shorthaired Pointer (n = 24) 1 – 23
Control German Shorthaired Pointer (n = 520) 457 63 –
Control German Longhaired Pointer (n = 52) 50 2 –
Control German Wirehaired Pointer (n = 210) 210 – –
Control Braque du Bourbonnais (n = 7) 7 – –
Affected Vizsla (n = 1) 1
Control Vizsla (n = 56) 51 5 –
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4. Discussion
In this study, we identified UNC93B1:pPro480Thr as a candidate causative variant for ECLE
in dogs. We performed a new GWAS and obtained the strongest association signal on the same
chromosome, but approximately 1 Mb more proximal than the location in the previously reported
GWAS [20]. Given that linkage disequilibrium within breeds can span several Mb, we consider our
new result a confirmation and refinement of the previously reported association. Compared to the
previous study [20], we detected a different ~500 kb homozygous haplotype block harboring the 7 top
markers of our GWAS that was shared among all 14 investigated ECLE cases.
Whole genome sequencing data of two cases and 654 controls revealed a single private protein
changing variant in the critical interval, UNC93B1:pPro480Thr. All but one of the designated ECLE
cases were homozygous for the mutant allele with the single discordant dog believed to represent a
phenotype mismatch. Conversely, the mutant allele was not found in a homozygous state in more
than 1000 control dogs.
The mutant allele was also detected in heterozygous status in controls of two related breeds,
German Longhaired Pointers and Vizslas. These breeds share a common ancestry with German
Shorthaired Pointers. This provides indirect support for the previous observation that ECLE also
can affect dogs from breeds related to the German Shorthaired Pointer. The hypothesis of a common
genetic defect in these breeds was confirmed by our finding of an ECLE affected Vizsla that was also
homozygous mutant at the UNC93B1 variant.
The UNC93B1 gene encodes a protein named “unc-93 homolog B1, TLR signaling regulator”.
The human UNC93B1 consists of 597 amino acids and is a 12 transmembrane domain containing protein
located in endosomal membranes [31]. It acts as a trafficking chaperone of the intracellular nucleic
acid-sensing Toll-like receptors (TLRs) 3, 7 and 9 [32–35]. These TLRs are essential components of the
innate immune system and activated when pathogen derived nucleic acids appear in endolysosomes.
UNC93B1 mediates the correct trafficking and localization of these TLRs to endolysosomes [32].
Complete loss-of-function of UNC93B1 results in a severe immune deficiency in human patients [36]
and the 3d mouse mutant [37].
Recently, the molecular mechanisms of the interaction of UNC93B1 with TLRs were studied in
great detail. A 33 amino acid sequence motif in the cytoplasmic C-terminal domain of UNC93B1 binds
to syndecan binding protein (SDCBP), also called syntenin-1. SDCBP interacts with both UNC93B1
and TLR7 [30]. This interaction dampens TLR7 signaling and prevents autoimmune activation of
TLR7 by endogenous nucleic acids [30,35]. Gene-edited mice expressing a mutant Unc93B1 in which
three critical amino acids of this C-terminal domain were altered (530-PKP/AAA-532) developed
hallmarks of systemic inflammation and autoimmunity [30], similar to what has been observed in
Tlr7 overexpressing mice [38–40]. In summary, the available literature suggests that complete loss of
function of UNC93B1 leads to an immune deficiency, while UNC93B1 variants that only affect the
C-terminal tail containing the SDCBP binding domain lead to upregulation of TLR7 signaling with
subsequent development of systemic autoimmune disease.
The detailed functional knowledge on the role of the C-terminal tail of UNC93B1 for the regulation
of TLR7 signaling strongly suggests that ECLE in dogs is due to dysregulated TLR7 signaling caused
by the canine UNC93B1:p.Pro480Thr variant.
To the best of our knowledge, ECLE affected dogs represent the first spontaneous UNC93B1
mutant that develops an autoimmune disease of the lupus group. Therefore, these dogs represent an
interesting model for human CLE and/or SLE. As already suggested by [30], it seems possible that
lupus erythematosus or other related autoimmune diseases in some human patients might be due to
comparable genetic variants in UNC93B1.
5. Conclusions
We identified the spontaneously arisen UNC93B1:p.Pro480Thr variant as likely causative for ECLE
in dogs. Knowledge of this variant will facilitate genetic testing of dogs to prevent the non-intentional
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breeding of ECLE-affected dogs. This unique canine form of CLE in dogs represents an interesting
model for lupus erythematosus and potentially other autoimmune diseases in humans.
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